Evidence map›Paper›PMID 41754466›Full record

ArticlePathogens (Basel, Switzerland)2026

In Vitro Evaluation of Colistin-Meropenem Activity Against XDR and PDR Carbapenemase-Producing

Shahinda Rezk, Nada Younis Elwakeel, Abeer Ghazal, Amel Elsheredy, Daniel Baecker, Ahmed Noby Amer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Multi-Route Administration Therapy for IntracranialInternational medical case reports journal · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shahinda RezkMicrobiology Department, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.ORCID 0000-0003-2916-6226
Nada Younis ElwakeelMicrobiology Department, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Abeer GhazalMicrobiology Department, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Amel ElsheredyMicrobiology Department, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.ORCID 0000-0001-6368-2596
Daniel BaeckerDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, 14195 Berlin, Germany.ORCID 0000-0002-1963-9838
Ahmed Noby AmerMicrobiology and Immunology Department, Faculty of Pharmacy and Drug Manufacturing, Pharos University in Alexandria, Canal El Mahmoudia Street, Beside Green Plaza Complex, Alexandria 21648, Egypt.ORCID 0000-0003-3610-4592

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesColistinDrug Resistance, Multiple, BacterialKlebsiella pneumoniaeMeropenemDrug SynergismHumansKlebsiella InfectionsMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseColistinMeropenemAcinetobacter baumanniicarbapenem-resistancecolistincombination therapyKlebsiella pneumoniaemeropenem

Identifiers

PMID41754466
PMCPMC12943050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.